Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes.

Sood P, Seth T, Kapil A, Sharma V, Dayama A, Sharma S, Kumar S, Singh AK, Mishra P, Mahapatra M.

J Indian Med Assoc. 2012 Jul;110(7):439-44.

PMID:
23520666
2.

Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.

Kunz AN, Brook I.

Chemotherapy. 2010;56(6):492-500. doi: 10.1159/000321018. Epub 2010 Nov 24. Review.

PMID:
21099222
3.
4.

Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.

Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, Hsueh PR.

Epidemiol Infect. 2010 Jul;138(7):1044-51. doi: 10.1017/S0950268809991208. Epub 2009 Nov 27.

PMID:
19941686
5.

Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.

Marin M, Gudiol C, Ardanuy C, Garcia-Vidal C, Calvo M, Arnan M, Carratalà J.

J Infect. 2014 Nov;69(5):417-23. doi: 10.1016/j.jinf.2014.05.018. Epub 2014 Jun 21.

PMID:
24960295
6.

Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.

Chen CY, Tang JL, Hsueh PR, Yao M, Huang SY, Chen YC, Chen YC, Shen MC, Wang CH, Tsai W, Chang SC, Tien HF, Luh KT.

J Formos Med Assoc. 2004 Jul;103(7):526-32.

PMID:
15318274
7.

Acinetobacter baumannii: an emerging opportunistic pathogen.

Howard A, O'Donoghue M, Feeney A, Sleator RD.

Virulence. 2012 May 1;3(3):243-50. doi: 10.4161/viru.19700. Epub 2012 May 1. Review.

8.

Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes.

Costa Pde O, Atta EH, Silva AR.

J Pediatr (Rio J). 2015 Sep-Oct;91(5):435-41. doi: 10.1016/j.jped.2014.11.009. Epub 2015 Jun 6.

9.

Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.

Chong Y, Shimoda S, Yakushiji H, Ito Y, Miyamoto T, Kamimura T, Shimono N, Akashi K.

PLoS One. 2013;8(1):e54190. doi: 10.1371/journal.pone.0054190. Epub 2013 Jan 23.

11.

A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.

Vasudevan A, Mukhopadhyay A, Li J, Yuen EG, Tambyah PA.

BMC Infect Dis. 2014 Nov 25;14:615. doi: 10.1186/s12879-014-0615-z.

12.

Invasive bacterial infections in a pediatric oncology unit in a tertiary care center.

Trehan A, Totadri S, Gautam V, Bansal D, Ray P.

Indian J Cancer. 2014 Oct-Dec;51(4):428-31. doi: 10.4103/0019-509X.175368.

14.
15.

Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat.

Wudhikarn K, Gingrich RD, de Magalhaes Silverman M.

Ann Hematol. 2013 Jan;92(1):129-31. doi: 10.1007/s00277-012-1539-6. Epub 2012 Aug 7. Review. No abstract available.

PMID:
22869090
16.

[Antibacterial drug resistance in Latin America: consequences for infectious disease control].

Casellas JM.

Rev Panam Salud Publica. 2011 Dec;30(6):519-28. Review. Spanish.

17.
18.

Opportunistic nosocomial multiply resistant bacterial infections--their treatment and prevention.

Bergogne-Bérézin E, Decré D, Joly-Guillou ML.

J Antimicrob Chemother. 1993 Jul;32 Suppl A:39-47. Review. Erratum in: J Antimicrob Chemother 1994 Dec;34(6):1083.

PMID:
7755661
19.

Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.

Kara Ö, Zarakolu P, Aşçioğlu S, Etgül S, Uz B, Büyükaşik Y, Akova M.

Infect Dis (Lond). 2015;47(10):686-93. doi: 10.3109/23744235.2015.1051105. Epub 2015 May 29.

PMID:
26024284
20.

Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.

Alp E, Esel D, Yildiz O, Voss A, Melchers W, Doganay M.

Scand J Infect Dis. 2006;38(5):335-40.

PMID:
16709534

Supplemental Content

Support Center